#Antigen

Hardy AIM 🎯

AimHardy

In arguably one of the most controversial U Turns since Nick Clegg on Tuition Fees...I have bought back more than I sold in #AVCT After a lot of recapping/further analysis

Katherine J. Wu, Ph.D.

KatherineJWu

Wired about LAMP testing, apparently, so a couple quick thoughts on this new at-home test (which requires a prescription!) before I attempt to sleep. 1/https://www.nytimes.com/live/2020/11/17/world/covid-19-coronavirus/fda-authorizes-the-fi

Michael Kronenberg

SubBasepair_Res

Interesting Merck valued VelosBio's ROR1-based antibody technology at 2.75 billion with only preclinical data available. VelosBio's VLS-101 is an antibody carrying a spindle poison payload, which is toxic to all

Ryan McNamara 🧬

Ryan_Mac_Phd

The J&J vaccine reportedly confers 85% protection after 1 month. Some suggest this could be improved with a booster. About that...J&J vaccine uses a replication-incompetent adenovirus (Ad26) to deliver the

John Bye

_johnbye

The government recently admitted its labs are struggling to meet demand, forcing them to ration access to testing to reduce delays and voided tests.Headline capacity figures look like they have

Subhasree Ray

DrSubhasree

Immunity and Nutrition: During #COVID19, immunity is the most used word. This thread will discuss:1. Different types of #Immunity & how they work?2. Role of protein, energy deficiency3. Role of

Shane Crotty

profshanecrotty

1/ This is one of the most interesting pre-prints I have seen this past month. I consider this study in two parts.https://www.biorxiv.org/content/10.1101/2020.11.03.367391v1 2/ In the first part, Nussenzweig and colleagues

Michael Mina

michaelmina_lab

UK Rolling out #COVID19 Rapid Tests! **NOTE: A quote says rapid tests missed 60% of positives in LiverpoolNOT accurateVAST majority of MISSES were LOW PCR RNA & thus NO LONGER

Sara Danner Dukic

saradannerdukic

It would be very useful to have an explanation from public health officials of differing viewpoints as to how they’ve arrived at the conclusion that COVID does or doesn’t spread

Ezra Klein

ezraklein

This is the part of the horror film where safety seems in sight, but it is obvious, to those paying attention, that the monster is not dead, and that the

Sara Sasse

waytoosasse

Let's talk about pediatric vaccines. Not COVID-19 yet (soon, @synapse2000 !), as I am waiting to hear back from some folks in the know, but a pediatric vaccination 101 for

Dan Larremore

DanLarremore

Preprint: COVID-19 screening and surveillance are critical, but molecular tests haven't come close to meeting needs, and temperature checks fail. We modeled the epidemiological impacts of using loss of smell

Patrick K A Kearns

kearnsneuro

Short vaccine : mRNA vaccines (Pfizer vs Moderna) *are very different to* Adenovirus virus vector vaccines (Oxford AZ and Johnson&Johnson). This will matter a lot.Dosing schedule of one, should not

Pharm. D

Pharmdca

$MREO Thread1)Focus of this thread: Etigilimab and AlvelestatFinancials: Roughly $200 million in cash (50M from upfront payment from Ultragenyx & $115M raise from a strong secondary last week). Company fully

Rebecca C. Christofferson 🤯

RC_Epi

Rapid #Covid antigen tests sacrifice sensitivity for cost and ease. this means the rate of false negatives is higher. some points: like all tests, a negative doesn’t mean anything for

Marion Koopmans

MarionKoopmans

Wow factor paper of the week: https://www.biorxiv.org/content/10.1101/2020.11.18.388819v1.full#ref-12Loss of taste and smell is a key symptom of COVID-19. This group studied infection of olfactory bulb sensory neural cells from nasal mucosa

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.